Abstract:High‐resolution landscapes of the entire tumor ecosystem from breast cancer liver and brain metastases are first depicted using single‐cell RNA sequencing. The metastatic breast cancer microenvironment features remarkable intratumoral heterogeneity and abundant immunosuppressive cells. This study provides unique insights into the immunotherapeutic strategies most appropriate for patients with liver or brain metastatic breast cancer. Distant metastasis remains the major cause of morbidity for breast cancer. Individuals with liver or brain metastasis have an extremely poor prognosis and low response rates to anti‐PD‐1/L1 immune checkpoint therapy compared to those with metastasis at other sites. Therefore, it is urgent to investigate the underlying mechanism of anti‐PD‐1/L1 resistance and develop more effective immunotherapy strategies for these patients. Using single‐cell RNA sequencing, a high‐resolution map of the entire tumor ecosystem based on 44 473 cells from breast cancer liver and brain metastases is depicted. Identified by canonical markers and confirmed by multiplex immunofluorescent staining, the metastatic ecosystem features remarkable reprogramming of immunosuppressive cells such as FOXP3+ regulatory T cells, LAMP3+ tolerogenic dendritic cells, CCL18+ M2‐like macrophages, RGS5+ cancer‐associated fibroblasts, and LGALS1+ microglial cells. In addition, PD‐1 and PD‐L1/2 are barely expressed in CD8+ T cells and cancer/immune/stromal cells, respectively. Interactions of the immune checkpoint molecules LAG3‐LGALS3 and TIGIT‐NECTIN2 between CD8+ T cells and cancer/immune/stromal cells are found to play dominant roles in the immune escape. In summary, this study dissects the intratumoral heterogeneity and immunosuppressive microenvironment in liver and brain metastases of breast cancer for the first time, providing insights into the most appropriate immunotherapy strategies for these patients.

Visualization of Human T Lymphocyte-Mediated Eradication of Cancer Cells in Vivo

Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish

Modeling Anti-Cd19 CAR T Cell Therapy in Humanized Mice with Human Immunity and Autologous Leukemia.

A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells in Vivo

Microfluidics guided by deep learning for cancer immunotherapy screening

Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish

In Vivo Visualization Of Tumor Antigen-Containing Microparticles Generated In Fluorescent-Protein-Elicited Immunity

Specificity redirection by CAR with human VEGFR-1 affinity endows T lymphocytes with tumor-killing ability and anti-angiogenic potency

Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor

Multi-parameter Optical Imaging of Immune Cell Activity in Chimeric Antigen Receptor T-cell and Checkpoint Blockade Therapies

3D live imaging and phenotyping of the subcellular cytotoxicity in cancer immunotherapy using event-triggered Bessel oblique plane microscopy

3D Microphysiological Tumor Model for Dual-Targeting CAR T Cell Immunotherapy

In Vivo Gene Editing of T-cells in Lymph Nodes for Enhanced Cancer Immunotherapy

Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models

Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy

The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer

Mechanism Study of Tumor-Specific Immune Responses Induced by Laser Immunotherapy

Engineering Chimeric Antigen Receptor-T Cells for Cancer Treatment

Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade Therapies